Literature DB >> 24482108

Neurological findings and genetic alterations in patients with Kostmann syndrome and HAX1 mutations.

Gaëlle Roques1, Martine Munzer, Marie-Anne Carpentier Barthez, Sandrine Beaufils, Blandine Beaupain, Terry Flood, Boris Keren, Christine Bellanné-Chantelot, Jean Donadieu.   

Abstract

OBJECTIVES: To describe the clinical profile and the prevalence of severe congenital neutropenia (SCN) and HAX1 mutations, so-called Kostmann syndrome, in France. STUDY
DESIGN: Two pedigrees were identified from the French registry.
RESULTS: The study included five subjects (three males), which represent 0.7% of the 759 SCN cases registered in France. The age at diagnosis was 0.3 years (range: 0.1-1.2 years) and the median age at the last follow-up was 7.3 years (range: 1.2-17.8 years). A novel large homozygous deletion of the HAX1 gene (exons 2-5) was found in one pedigree; while, a homozygous frameshift mutation was identified in exon 3 (c.430dupG, p.Val144fs) in the second pedigree. Severe bacterial infections were observed in four patients, including two cases of sepsis, one case of pancolitis, a lung abscess, and recurrent cellulitis and stomatitis. During routine follow-up, the median neutrophil value was 0.16 × 10(9)/L, associated with monocytosis (2 × 10(9)/L). Bone marrow (BM) smears revealed a decrease of the granulocytic lineage with no mature myeloid cells above the myelocytes. One patient died at age 2 from neurological complications, while two other patients, including one who underwent a hematopoietic stem cell transplantation (HSCT) at age 5, are living with very severe neurological retardation.
CONCLUSIONS: SCN with HAX1 mutations, is a rare sub type of congenital neutropenia, mostly observed in population from Sweden and Asia minor, associating frequently neurological retardation, when the mutations involved the B isoform of the protein.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  HAX1; encephalopathy; severe congenital neutropenia

Mesh:

Substances:

Year:  2014        PMID: 24482108     DOI: 10.1002/pbc.24964

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  6 in total

1.  Gene correction of HAX1 reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cells.

Authors:  Erik Pittermann; Nico Lachmann; Glenn MacLean; Stephan Emmrich; Mania Ackermann; Gudrun Göhring; Brigitte Schlegelberger; Karl Welte; Axel Schambach; Dirk Heckl; Stuart H Orkin; Tobias Cantz; Jan-Henning Klusmann
Journal:  Blood Adv       Date:  2017-06-02

2.  Delayed Puberty and Gonadal Failure in Patients with HAX1 Mutation.

Authors:  Sukru Cekic; Halil Saglam; Orhan Gorukmez; Tahsin Yakut; Omer Tarim; Sara S Kilic
Journal:  J Clin Immunol       Date:  2017-07-05       Impact factor: 8.317

Review 3.  Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1).

Authors:  Christoph Klein
Journal:  J Clin Immunol       Date:  2016-12-10       Impact factor: 8.317

Review 4.  Approach to the patient with neutropenia in childhood.

Authors:  Tiraje Celkan; Begüm Şirin Koç
Journal:  Turk Pediatri Ars       Date:  2015-09-01

5.  A Rare Case of Kostmann Syndrome Presenting Difficult Airway Challenges and Patient Preparedness for Anesthesiologists.

Authors:  Vamsi Krishna Uppalapati; Ashok Chattoraj; Deb Sanjay Nag; Himanshu Kumar; Sharad Kumar
Journal:  Cureus       Date:  2022-07-18

Review 6.  The role of neutrophils in host defense and disease.

Authors:  Heather K Lehman; Brahm H Segal
Journal:  J Allergy Clin Immunol       Date:  2020-04-10       Impact factor: 14.290

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.